Novo Nordisk GLP-1 competition Warning with new pill rival
Can Novo Nordisk defend its GLP-1 dominance as a potent oral rival emerges and a bold US telehealth deal reshapes distribution? How does Structure Therapeutics challenge Novo Nordisk?The…
Tesla Robotaxi Strategy Boom as EV Sales Plunge
Can Tesla’s bold Robotaxi Strategy and energy storage pivot really justify a trillion-dollar valuation as its core EV business slows? How is Tesla reshaping its growth story?Tesla Transformation…